Treatable state possible for neuroendocrine prostate cancer.

Depleting a specific protein may restore treatment response in drug-resistant neuroendocrine prostate cancer.

Related Keywords

Canada ,United Kingdom ,Finland ,Finnish ,British ,Kirsi Ketola ,University Of Eastern Finland ,Ketola Lab ,Cancer Foundation Of Finland ,University Of British Columbia ,Finnish Cultural Foundation North Savo Regional Fund ,Academy Research Fellow Ketola ,Academy Research ,Nature Communications Biology ,Finnish Cultural Foundation ,Research Council Of Finland ,Eastern Finland ,Academy Research Fellow ,British Columbia ,Tissue Imaging Unit ,Research Fellow Ketola ,Research Council ,Sigrid Jus ,Cancer Foundation ,